Skip to main content
. 2024 Sep 16;40(2):491–503. doi: 10.1007/s00467-024-06487-2

Fig. 2.

Fig. 2

Cumulative incidence of acute antibody-mediated rejection (ABMR) and chronic active ABMR during the first 5 years post-transplant. The red line indicates acute ABMR; the blue line indicates chronic active ABMR; shaded areas indicate 95% confidence interval